Shelby Crawford
Overview
Explore the profile of Shelby Crawford including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
232
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Soroosh P, Wu J, Xue X, Song J, Sutton S, Sablad M, et al.
Proc Natl Acad Sci U S A
. 2014 Aug;
111(33):12163-8.
PMID: 25092323
The RAR-related orphan receptor gamma t (RORγt) is a nuclear receptor required for generating IL-17-producing CD4(+) Th17 T cells, which are essential in host defense and may play key pathogenic...
2.
Eccles W, Blevitt J, Booker J, Chrovian C, Crawford S, de Leon A, et al.
Bioorg Med Chem Lett
. 2012 Dec;
23(3):811-5.
PMID: 23260350
Leukotrienes (LT's) are known to play a physiological role in inflammatory immune response. Leukotriene A(4) hydrolase (LTA(4)H) is a cystolic enzyme that stereospecifically catalyzes the transformation of LTA(4) to LTB(4)....
3.
Tanis V, Bacani G, Blevitt J, Chrovian C, Crawford S, De Leon A, et al.
Bioorg Med Chem Lett
. 2012 Nov;
22(24):7504-11.
PMID: 23127888
Previously, benzthiazole containing LTA(4)H inhibitors were discovered that were potent (1-3), but were associated with the potential for a hERG liability. Utilizing medicinal chemistry first principles (e.g., introducing rigidity, lowering...
4.
Rao N, Riley J, Banie H, Xue X, Sun B, Crawford S, et al.
Am J Respir Crit Care Med
. 2010 Jan;
181(9):899-907.
PMID: 20110560
Rationale: Allergic asthma is characterized by reversible airway obstruction, lung inflammation, and airway hyperresponsiveness (AHR). Previous studies using leukotriene B(4) (LTB(4)) receptor 1-deficient mice and adoptive transfer experiments have suggested...
5.
Wolin R, Bembenek S, Wei J, Crawford S, Lundeen K, Brunmark A, et al.
Bioorg Med Chem Lett
. 2008 Apr;
18(9):2825-9.
PMID: 18434146
Computer aided modeling guided the design of a series of diarylimidazole compounds (11-22) intended to interact with both the ATP and adjacent allosteric binding domains of B-RAF kinase. Their ability...
6.
Crawford S, Belajic D, Wei J, Riley J, Dunford P, Bembenek S, et al.
Mol Cancer Ther
. 2008 Mar;
7(3):492-9.
PMID: 18347137
B-RAF mutations have been identified in the majority of melanoma and a large fraction of colorectal and papillary thyroid carcinoma. Drug discovery efforts targeting mutated B-RAF have yielded several interesting...
7.
Checkpoint kinase inhibitors: SAR and radioprotective properties of a series of 2-arylbenzimidazoles
Arienti K, Brunmark A, Axe F, McClure K, Lee A, Blevitt J, et al.
J Med Chem
. 2005 Mar;
48(6):1873-85.
PMID: 15771432
The discovery of a series of novel, potent, and highly selective inhibitors of the DNA damage control kinase chk2 is disclosed. Here we report the first SAR study around inhibitors...